Danaher
Top Five Articles on 360Dx Last Week: Dx Companies' Plans for POC Testing; IVDR Rollout; More
Last week, readers were most interested in a story about the hurdles faced by companies bringing routine testing at the point of care.
Danaher Agrees to Provide Cepheid Tuberculosis Test to Global Fund at Cost
The tuberculosis test cartridges will be offered at $7.97 each to the Global Fund and less-developed countries eligible for Cepheid's Global Access Program.
In Brief This Week: Quest Diagnostics, Danaher, Trinity Biotech, Oncgnostics, Prenetics
News items for the week of Sept. 11, 2023
Top Five Articles on 360Dx Last Week: Bionano Partner Nabs NMPA Approval; Danaher's $5.7B Buy; More
Last week, readers were most interested in a story about Bionano's OEM Partner in China nabbing approval for the firm's DNA extraction and labeling products.
Danaher to Acquire Abcam for $5.7B
Cambridge, UK-based Abcam provides antibodies, reagents, biomarkers, and assays for drug discovery, life sciences research, and diagnostics.